EECP for Long COVID: What the Evidence Shows
Long COVID is, at its core, a vascular disease. The persistent fatigue, brain fog, shortness of breath, and autonomic dysfunction that define it are increasingly understood as consequences of endothelial injury and microvascular dysfunction. EECP addresses exactly those mechanisms.
What long COVID actually is
Long COVID — also called post-acute sequelae of SARS-CoV-2 (PASC) — is a syndrome of persistent symptoms following COVID-19 infection, lasting more than 12 weeks after the acute illness. It affects an estimated 10–30% of COVID-19 survivors. Symptoms include fatigue, cognitive impairment ('brain fog'), shortness of breath, post-exertional malaise, autonomic dysfunction (POTS), chest pain, and reduced exercise tolerance.
The vascular mechanism
The pathophysiology of long COVID is still being characterized, but a strong body of evidence points to endothelial dysfunction and microvascular injury as central mechanisms. SARS-CoV-2 directly infects endothelial cells (the cells lining blood vessels), triggering inflammation, microclot formation, and impaired nitric oxide production. The result is reduced blood flow to tissues — including the brain, heart, and skeletal muscle — that explains many of the characteristic symptoms.
EECP's primary mechanism is improving endothelial function and promoting microvascular circulation. It increases nitric oxide production, reduces arterial stiffness, and promotes angiogenesis (new blood vessel formation). These are precisely the mechanisms disrupted in long COVID.
What the evidence shows
Clinical evidence for EECP in long COVID is early but consistent. A 2022 observational study published in the European Heart Journal — Cardiovascular Pharmacotherapy reported significant improvements in SF-36 quality-of-life scores across multiple domains in long COVID patients treated with EECP. Patients reported improvements in physical function, fatigue, cognitive function, and general health. A 2023 case series documented improvement in POTS symptoms and exercise tolerance in long COVID patients following a standard 35-hour EECP course.
- →Improved physical function and exercise tolerance
- →Reduced fatigue scores
- →Improved cognitive function and reduced brain fog
- →Improvement in POTS symptoms (heart rate dysregulation)
- →Improved general health and quality of life scores
Why EECP makes mechanistic sense for long COVID
Beyond the clinical evidence, EECP makes mechanistic sense for long COVID in a way that few other therapies do. Most treatments for long COVID are symptomatic — they address individual symptoms without targeting the underlying vascular pathology. EECP targets the endothelial dysfunction and microvascular injury that appear to drive the syndrome. It's not a cure, and the evidence base is still developing, but the mechanistic rationale is strong.
What patients with long COVID should know
EECP is not a standard treatment for long COVID, and it should not be presented as one. The evidence is observational and the sample sizes are small. But for patients who have not responded to other approaches and whose symptoms suggest a vascular component — fatigue, cognitive impairment, exercise intolerance, POTS — EECP is a reasonable option to discuss with a knowledgeable provider.
Practical considerations
Long COVID patients considering EECP should be aware that post-exertional malaise (PEM) — the worsening of symptoms after physical or cognitive exertion — is a feature of some long COVID presentations. EECP is passive (you lie still during treatment), so it does not trigger PEM in the way that exercise might. However, some patients experience fatigue in the first week of treatment, which is normal and typically resolves. Starting at lower cuff pressures and building gradually is appropriate for long COVID patients.
Medical disclaimer: This article is for informational purposes only and does not constitute medical advice. EECP therapy should be considered in consultation with a qualified healthcare provider who can evaluate your individual clinical situation. Atlantic EECP does not provide diagnosis or treatment recommendations without a clinical evaluation.
Jack Clifford's definitive patient guide — the science, the history, the politics, and the practical reality of EECP. The book I wish I'd had in that hospital bed.